Aiming To End Parkinson’s Disease

Each year, almost 60,000 Americans are diagnosed with Parkinson’s disease (PD), but some of those patients might soon find relief for themselves and their families. Groundbreaking research at The Ohio State University Wexner Medical Center Neurological Institute suggests that transformational gene therapy could disrupt the circuits of neurodegenerative diseases, like Parkinson’s, to stop its progression through a one-time treatment that could halt the disease. Six clinical trials are currently in progress, and previous tests proved so effective that the Food and Drug Administration has helped to fast-track the registration of the therapy, which may be approved for treatment of patients this year.

For more information, visit medicine.osu.edu.

Comments

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Similar Articles

Most Popular

Day tripping to Frankenmuth

Great options for exploring are a short drive away.  Maybe you only have a few days to travel, didn’t get your planning done early,...

Nature’s Nursery launches “The Nest We Need,” fundraiser

Nature’s Nursery rescues and rehabilitates thousands of animals each year. Posting photos of their latest rescues on Instagram or hosting educational nature programs for...

Dr. Strange in The Multiverse of Madness Review: Campy Horror Fans Rejoice

The newest installment of the ever-expanding Marvel Cinematic Universe comes Dr. Strange in the Multiverse of Madness. Directed by Sam Raimi, the horror savant behind...